Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT01901146
Title Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Subjects With HER2 Positive Early Breast Cancer (Lilac)
Acronym Lilac
Recruitment Completed
Gender female
Phase Phase III
Variant Requirements No
Sponsors Amgen
Age Groups: adult
Covered Countries ITA | GBR | ESP | DEU | CAN

No variant requirements are available.